{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:02:51Z","timestamp":1791903771389,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RA 2435\/3-1"],"award-info":[{"award-number":["RA 2435\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 815\/3 A16"],"award-info":[{"award-number":["SFB 815\/3 A16"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.metabol.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:22:35Z","timestamp":1540347755000},"page":"16-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Association between arginase-containing platelet-derived microparticles and altered plasma arginine metabolism in polycystic ovary syndrome"],"prefix":"10.1016","volume":"90","author":[{"given":"Anastasia","family":"Kyselova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Hinrichsmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Zukunft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke","family":"Dornauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voahanginirina","family":"Randriamboavonjy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2018.10.008_bb0005","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2018.10.008_bb0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2018.10.008_bb0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1530\/EJE-11-0755","article-title":"Recent advances in cardiovascular aspects of polycystic ovary syndrome","volume":"166","author":"Sathyapalan","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2018.10.008_bb0020","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1210\/jc.2002-021391","article-title":"Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity","volume":"88","author":"Dereli","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.10.008_bb0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.atherosclerosis.2008.09.010","article-title":"Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects","volume":"204","author":"Rajendran","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2018.10.008_bb0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/09513590802291824","article-title":"Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome","volume":"24","author":"Karakurt","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.metabol.2018.10.008_bb0035","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jcem.87.8.8716","article-title":"Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state","volume":"87","author":"Yildiz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.10.008_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101219","article-title":"Predictive properties of plasma amino acid profile for cardiovascular disease in patients with type 2 diabetes","volume":"9","author":"Kume","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.10.008_bb0045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.20030694","article-title":"Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway","volume":"199","author":"Randriamboavonjy","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2018.10.008_bb0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00726-008-0210-y","article-title":"Arginine metabolism and nutrition in growth, health and disease","volume":"37","author":"Wu","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.metabol.2018.10.008_bb0055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cvr\/cvt036","article-title":"Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?","volume":"98","author":"Pernow","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2018.10.008_bb0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/dc07-1198","article-title":"Insulin reduces plasma arginase activity in type 2 diabetic patients","volume":"31","author":"Kashyap","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2018.10.008_bb0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.295.1.58","article-title":"L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial","volume":"295","author":"Schulman","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2018.10.008_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/toxsci\/kfs243","article-title":"A performance evaluation of three drug-induced liver injury biomarkers in the rat: alpha-glutathione S-transferase, arginase 1, and 4-hydroxyphenyl-pyruvate dioxygenase","volume":"130","author":"Bailey","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.metabol.2018.10.008_bb0075","doi-asserted-by":"crossref","first-page":"42798","DOI":"10.1038\/srep42798","article-title":"Hepatocyte-secreted extracellular vesicles modify blood metabolome and endothelial function by an arginase-dependent mechanism","volume":"7","author":"Royo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2018.10.008_bb0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1096-7192(02)00034-3","article-title":"Expression of the liver form of arginase in erythrocytes","volume":"76","author":"Kim","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2018.10.008_bb0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1515\/cclm-2013-0698","article-title":"Increased plasma arginase activity in human sepsis: association with increased circulating neutrophils","volume":"52","author":"Darcy","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.metabol.2018.10.008_bb0090","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1055\/s-0030-1267042","article-title":"Platelet- and megakaryocyte-derived microparticles","volume":"36","author":"Flaumenhaft","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.metabol.2018.10.008_bb0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fcvm.2017.00074","article-title":"Platelet-derived microvesicles in cardiovascular diseases","volume":"4","author":"Zaldivia","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.metabol.2018.10.008_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/EJE-11-0144","article-title":"Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels","volume":"165","author":"Koiou","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2018.10.008_bb0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/09513590.2012.743005","article-title":"Platelet-derived microparticles in overweight\/obese women with the polycystic ovary syndrome","volume":"29","author":"Koiou","year":"2013","journal-title":"Gynecol Endocrinol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049518302269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049518302269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:18:46Z","timestamp":1758428326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049518302269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":21,"alternative-id":["S0026049518302269"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2018.10.008","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between arginase-containing platelet-derived microparticles and altered plasma arginine metabolism in polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}